• FDA joins Bespoke Gene Therapy Consortium (BGTC) for rare diseases EuropeanPharmaceuticalReview
    October 29, 2021
    The US Food and Drug Administration (FDA), the National Institutes of Health (NIH), 10 pharmaceutical companies and five non-profit organisations have partnered to accelerate development of gene therapies​ for rare diseases.
PharmaSources Customer Service